QUCY
NasdaqQuantum Cyber N.V.
Basic Materials · Pharmaceutical Preparations
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
🔒 price chart needs market-data feed$893,991
2024
$537,080
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$537,080
Net Income$-16.2M
Gross Profit$389,792
Oper Income$-16.1M
EPS (dil)$-2.70
Rev/sh$0.04
FCF/sh$-0.75
Book/sh$0.04
Gross M72.6%
Oper M-3005.0%
Profit M-3018.3%
FCF M-2044.5%
ROE-2526.6%
ROA-304.3%
ROIC—
R&D/Rev913.4%
Rev Y/Y-39.9%
Rev 3Y CAGR—
EPS Y/Y87.7%
EPS 3Y CAGR—
FCF 3Y CAGR—
Payout—
Div/sh—
Shs Chg Y/Y+508.4%
Current Ratio0.90
Quick Ratio0.85
Debt/Eq—
Int Coverage-43.2×
Net Debt—
Total Debt—
Cash & Eq$889,091
Total Assets$5.3M
Oper CF$-11.0M
Capex$1,216
Free CF$-11.0M
Buybacks—
Equity$641,600
Liabilities$4.7M
Shs Outstand0.01B
SectorBasic Materials
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 2 FY| USD | FY2024 | FY2025 |
|---|---|---|
| Revenue | $893,991 | $537,080 |
| Gross Profit | $574,883 | $389,792 |
| Operating Income | $-18.8M | $-16.1M |
| Net Income | $-21.6M | $-16.2M |
| Diluted EPS | $-21.91 | $-2.70 |
| Operating Cash Flow | $-17.3M | $-11.0M |
| Free Cash Flow | $-17.4M | $-11.0M |
COMMUNITY · $QUCY0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.